Clinical TrialsSearch results
Number of results: 284
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Long-term follow-up of TBI-1301
- relapsed or refractory solid tumors
- Watanabe Takashi
- 2022-03-17
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
- Refractory (drug resistant) nephrotic syndrome
- the Japanese Society of Kidney and Lipids Research
- 2007-11-01
Other
- The evaluation of supportive care for hand-foot syndrome and stomatitis in patients with recurrent/ relapsed Müllerian carcinoma received chemotherapy of pegylated liposomal doxorubicin
- Recurrent/ Relapsed Müllerian carcinoma
- Japan Doxil study group
- 2009-05-18
Other
- A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.
- Rectal Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-04-01
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Follow-up study for localized prostate cancer treated by hormonal therapy or radical prostatectomy.
- Prostate cancer
- J-CaP study group
- 2006-12-30
Other
- Outcome study of hormonal therapy for prostate cancer in Japan
- Prostate cancer
- J-CaP study group
- 2005-09-29
Other
- Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401)
- prostate cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13